UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

The New England journal of medicine, 2012-03, Vol.366 (10), p.925-931

2012

Link zum Volltext

Verfügbarkeit prüfen

Tumor‐associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma

Cancer science, 2018-03, Vol.109 (3), p.863-870

2018

Link zum Volltext

Verfügbarkeit prüfen

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports

BMC cancer, 2019-10, Vol.19 (1), p.1019-1019, Article 1019

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

Cancer science, 2018-11, Vol.109 (11), p.3583-3590

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients

Cancer science, 2016-12, Vol.107 (12), p.1730-1735

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for genitourinary tumors

International journal of urology, 2019-03, Vol.26 (3), p.326-333

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Development of Immune Checkpoint Inhibitors

BioMed research international, 2015-01, Vol.2015, p.605478-12

2015

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer

Cancer science, 2020-07, Vol.111 (7), p.2647-2654

2020

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for Immune Checkpoint Inhibitors in Melanoma

Frontiers in oncology, 2018-07, Vol.8, p.270-270

2018

Link zum Volltext

Verfügbarkeit prüfen

CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer

Scientific reports, 2021-11, Vol.11 (1), p.22495-22495, Article 22495

2021

Link zum Volltext

Verfügbarkeit prüfen

AJS-4 Current status and future challenges in clinical development of CAR-T cell therapy and bispecific antibody therapy for solid tumors

Annals of oncology, 2023-11, Vol.34, p.S1349-S1349

Kitano, Shigehisa

2023

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Oncotarget, 2016-11, Vol.7 (47), p.77404-77415

2016

Link zum Volltext

Verfügbarkeit prüfen

CD20+ tumor‐infiltrating immune cells and CD204+ M2 macrophages are associated with prognosis in thymic carcinoma

Cancer science, 2020-06, Vol.111 (6), p.1921-1932

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression

Scientific reports, 2022-05, Vol.12 (1), p.8098-8098, Article 8098

2022

Link zum Volltext

Verfügbarkeit prüfen

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

British journal of cancer, 2020-02, Vol.122 (3), p.413-420

2020

Link zum Volltext

Verfügbarkeit prüfen

SY14-2 Strategies for cancer immunotherapy based on breast cancer microenvironment

Annals of oncology, 2022-07, Vol.33, p.S438

Kitano, Shigehisa

2022

Link zum Volltext

Verfügbarkeit prüfen

EL03 Basics of tumor immunology

Annals of oncology, 2022-07, Vol.33, p.S457

Kitano, Shigehisa

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B)

European journal of cancer (1990), 2022-08, Vol.171, p.193-202

2022

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting

British journal of cancer, 2022-03, Vol.126 (4), p.606-614

2022

Link zum Volltext

Verfügbarkeit prüfen

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs

Breast cancer research : BCR, 2022-10, Vol.24 (1), p.1-67, Article 67

2022

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma

Oncotarget, 2016-07, Vol.7 (30), p.47252-47264

2016

Link zum Volltext

Verfügbarkeit prüfen

DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel

Lung cancer (Amsterdam, Netherlands), 2017-08, Vol.110, p.26-31

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E)

Future oncology (London, England), 2020-07, Vol.16 (19), p.1351

2020

Link zum Volltext

Verfügbarkeit prüfen

Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment

Breast cancer research : BCR, 2023-01, Vol.25 (1), p.13-13, Article 13

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study

Investigational new drugs, 2021-12, Vol.39 (6), p.1559-1567

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Englisch
(186)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Tumor‐associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma

Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients

Immunotherapy for genitourinary tumors

Clinical Development of Immune Checkpoint Inhibitors

Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer

Biomarkers for Immune Checkpoint Inhibitors in Melanoma

CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer

AJS-4 Current status and future challenges in clinical development of CAR-T cell therapy and bispecific antibody therapy for solid tumors

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

CD20+ tumor‐infiltrating immune cells and CD204+ M2 macrophages are associated with prognosis in thymic carcinoma

Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression

Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma

SY14-2 Strategies for cancer immunotherapy based on breast cancer microenvironment

EL03 Basics of tumor immunology

Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B)

Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs

Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma

DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel

Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E)

Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment

Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study

Suchergebnisse filtern